Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shan Shang Water for Allergic Rhinitis
NCT06756243Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Mar 2025
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Randomised, double-blind trial in allergic rhinitis (AR) (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoints: Total Nasal Symptom Score at 24 weeks, Total Non-Nasal Symptom Score at 24 weeks and 6 more. Planned start Mar 2025; status: not yet recruiting.
02
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT06756243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06756243.